17 June 2021

Imperial partner Apollo receives £100m to boost medical research at leading unis

09 June 2021

Podcast explores new frontiers in analytical science

28 May 2021

Key enzyme aggravates colorectal cancer in obese patients

27 April 2021

New study reveals weak spots in chemotherapy-resistant cancer cells

07 April 2021

Cancer drugs could be delivered in molecular cages unlocked by light

23 February 2021

ADC Therapeutics to develop anti-cancer drugs in new White City Campus centre

04 February 2021

Imperial staff reflect on a challenging year – and their hopes for the future

30 November 2020

Imperial set to lead UK trial of innovative new cancer drug

16 November 2020

Imperial startup wins £4.5m investment to develop new cancer drugs

13 November 2020

Molecular insights into key drug target could help to enhance cancer treatments

12 November 2020

New anti-cancer drug combo treatment shows promise for myeloma patients

07 October 2020

Cancer-causing HTLV-1 virus hijacks cellular machinery to establish infection